T. Muraleedharan and A. Balan, “Integrating Immunotherapy and Targeted Therapy in Advanced Hepatocellular Carcinoma: Clinical Outcomes of Lenvatinib–Pembrolizumab Combination Therapy”, Int J Med Stud, Aug. 2026.